PsiQuantum has partnered with the National Cancer Center of Japan to advance quantum computing in oncology and healthcare.[1] The companies signed a research agreement to develop applications for quantum computers in drug discovery and cancer treatment.[1][2] The goal is to advance the development of robust quantum algorithms and collaborate with Japanese pharmaceutical firms on clinically relevant quantum applications.[1] The partnership will use PsiQuantum's software suite called Construct, which is used to design, analyze and optimize algorithms for resilient quantum computing.[1] Sam Pallister, PsiQuantum's vice president of quantum applications, said that quantum computers will accelerate the development of new drugs to benefit researchers and patients.[1] dr. Takayuki Yoshino, from the Department of Global Oncology at the National Cancer Center in Japan, highlighted the potential of quantum technologies in solving healthcare challenges.[1] The National Cancer Center of Japan is a leading facility for cancer treatment and research.[1]